Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000424327 | SCV000515914 | benign | not specified | 2016-09-22 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Laboratory for Molecular Medicine, |
RCV000424327 | SCV000711861 | benign | not specified | 2016-03-21 | criteria provided, single submitter | clinical testing | p.Gly1414Ala in exon 8 of ALMS1: This variant is not expected to have clinical s ignificance because it has been identified in 87.82% (1161/1322) of African chro mosomes by the 1000 Genomes Project (Phase 3; dbSNP rs6546837). |
Labcorp Genetics |
RCV000860243 | SCV001000225 | benign | Alstrom syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000860243 | SCV001769055 | benign | Alstrom syndrome | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002328930 | SCV002628663 | benign | Cardiovascular phenotype | 2018-12-21 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV004708799 | SCV005242453 | benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV000860243 | SCV001463043 | benign | Alstrom syndrome | 2020-09-16 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000424327 | SCV001742171 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000424327 | SCV001917973 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000424327 | SCV001953918 | benign | not specified | no assertion criteria provided | clinical testing |